CHRO Chromocell Therapeutics
- 1.400
- +0.060+4.48%
Chromocell Therapeutics News
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) stock increased by 173.2% to $1.12 during Wednesday's regular session. The market value of their outstanding shares is at $19.6 million. Reshape Lifesciences (N
Chromocell Therapeutics (CHRO.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -0.55 dollars, previous value of -0.87 dollars.
Chromocell Therapeutics (CHRO.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0; earnings per share were -0.55 dollars, previous value of -0.87 dollars.
Chromocell Therapeutics | 10-Q: Quarterly report
Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 2024
The conference provides Alliance Global Partners' top healthcare companies with an opportunity to discuss what they think are important industry catalysts and share some input on where they see the industry progressing in the coming months and years.
SBFM, BPTH and INDO Among Pre-market Losers
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with t
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersINVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Shares of INVO Bioscience, Inc. (NASDAQ:INVO) rose sharply in today's pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,38
IBio, ImmunityBio, Mesoblast Among Healthcare Movers
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. ("Chromocell", or the "Company"), (NYSE:CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced
Chromocell Therapeutics Appoints Experienced CEO Francis Knuettel II
Chromocell Therapeutics : Frank Knuettel Appointed as Permanent CEO >CHRO
Chromocell Therapeutics : Frank Knuettel Appointed as Permanent CEO >CHRO
Press Release: Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023 FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. ("Chromocell"
Chromocell Therapeutics Showcases Pipeline at Sidoti Conference
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. ("Chromocell", or the "Company"), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment the
13G Shows Boswell Prayer Ltd Reports 8.2% Passive Stake In Chromocell Therapeutics Corp As Of Feb 21
13G Shows Boswell Prayer Ltd Reports 8.2% Passive Stake In Chromocell Therapeutics Corp As Of Feb 21
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC ("Benuvia"), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. ("Chromocell"), (NYSE American: CHRO),
Singapore's Mobile-health Network Files for $10M US IPO
Analysis
Price Target
No Data
